Skip to main content
Log in

Continuous renal replacement therapy with a polymethyl methacrylate membrane hemofilter suppresses inflammation in patients after open-heart surgery with cardiopulmonary bypass

  • Original Article
  • Cardiopulmonary Bypass
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Cardiopulmonary bypass (CPB) induces a complex inflammatory response involving an increase in inflammatory cytokines, called postperfusion syndrome. Previous studies demonstrated that adsorption of the serum cytokines can reduce acute inflammation and improve clinical outcomes. In this study, patients were placed on continuous renal replacement therapy (CRRT) with a polymethyl methacrylate (PMMA) membrane hemofilter immediately after the start of an open-heart surgery with CPB and throughout the postoperative course to prevent postperfusion syndrome. The aim of this study was to assess whether continuous CRRT using a PMMA filter (PMMA–CRRT) could affect cytokine expression and improve perioperative outcomes. We designed a randomized controlled trial, which included 19 consecutive adult patients on maintenance dialysis and 7 consecutive adult patients who were not on maintenance dialysis (NHD group). Patients on maintenance dialysis were randomly divided into two groups: Ten patients who received CRRT with a polysulfone membrane hemofilter (PS group) and nine patients who received CRRT with a PMMA membrane (PMMA group). Blood samples were collected from the radial or brachial artery at five different time points. Comparisons between the PS, PMMA, and NHD groups revealed a significant main effect of time on changes in serum IL-6 and IL-8 concentrations (p < 0.01) and an interaction (p < 0.05) between time and group. Plasma IL-6 and IL-8 levels after surgery were significantly lower in the PMMA group than in the PS group, while other cytokines measured in this study were not significantly different. In addition, clinical outcomes were not significantly different between the groups. The continuous use of PMMA-CRRT throughout the perioperative period suppressed serum IL-6 and IL-8 concentrations, although there were no differences in clinical outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Westaby S. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit. Intensive Care Med. 1987;13(2):89–95.

    Article  PubMed  CAS  Google Scholar 

  2. Kawamura T, Wakusawa R, Okada K, Inada S. Evaluations of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth. 1993;40:1016–21.

    Article  PubMed  CAS  Google Scholar 

  3. Sawa Y, Shimazaki Y, Kadoba K, Masai T, Fukuda H, Ohata T, et al. Attenuation of cardiopulmonary bypass derived inflammatory reactions reduces myocardial reperfusion injury in open heart surgery. J Thorac Cardiovasc Surg. 1996;111:29–35.

    Article  PubMed  CAS  Google Scholar 

  4. Engels M, Bilgic E, Pinto A, Vasquez E, Wollschläger L, Steinbrenner H, et al. A cardiopulmonary bypass with deep hypothermic circulatory arrest rat model for the investigation of the systemic inflammation response and induced organ damage. J Inflamm. 2014;12:11: 26.

    Article  CAS  Google Scholar 

  5. Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Miyazaki M. Immunosuppression following surgical and traumatic injury. Surg Today. 2010;40(9):793–808.

    Article  PubMed  CAS  Google Scholar 

  6. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997;112:676–92.

    Article  PubMed  CAS  Google Scholar 

  7. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg. 1993;7:563–73.

    Article  PubMed  CAS  Google Scholar 

  8. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845–57.

    PubMed  CAS  Google Scholar 

  9. Steinberg J, Fink G, Picone A, Searles B, Schiller H, Lee HM, et al. Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass. J Extra Corpor Technol. 2001;33(4):218 – 22.

    PubMed  CAS  Google Scholar 

  10. Prasad A, Stone GW, Holmes DR, Gersh B. Reperfusion injury, microvascular dysfunction, and cardioprotection: the dark side of reperfusion. Circulation. 2009;120(21):2105–12.

    Article  PubMed  Google Scholar 

  11. Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol. 2011;301(5):H1723-H1741.

    Article  CAS  Google Scholar 

  12. Maganti M, Badiwala M, Sheikh A, Scully H, Feindel C, David TE, et al. Predictors of low cardiac output syndrome after isolated mitral valve surgery. J Thorac Cardiovasc Surg. 2010;140(4):790–6.

    Article  PubMed  Google Scholar 

  13. Stenvinkel P, Heimbürger O, Lindholm B, Kaysen GA, Bergström J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation, and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15:953–60.

    Article  PubMed  CAS  Google Scholar 

  14. Herbelin A, Ureña P, Nguyen AT, Zingraff J, Descamps-Latscha B. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 1991;39(5):954 – 60.

    Article  PubMed  CAS  Google Scholar 

  15. Shann KG, Likosky DS, Murkin JM, Baker RA, Baribeau YR, DeFoe GR, et al. An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution, and the inflammatory response. J Thorac Cardiovasc Surg. 2006; 132(2):283 – 90.

    Article  PubMed  Google Scholar 

  16. Jiménez JJ, Iribarren JL, Brouard M, Hernández D, Palmero S, Jiménez A, et al. Safety and Effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dosedependent, phase IV clinical trial. J Cardiothorac Surg. 2011;14:6: 138.

    Article  Google Scholar 

  17. Zhang X, Zhou C, Zhuang J, Xiao X, Zheng S, Xiong W, et al. Effects of leukocyte depletion on cardiopulmonary protection and inflammation after valve surgery. Int J Artif Organs. 2010;33(11):812–8.

    Article  PubMed  Google Scholar 

  18. Blomquist S, Gustafsson V, Manolopoulos T, Pierre L. Clinical experience with a novel endotoxin adsorbtion device in patients undergoing cardiac surgery. Perfusion. 2009;24(1):13–7.

    Article  PubMed  CAS  Google Scholar 

  19. Pathan N, Hemingway CA, Alizadeh AA, Stephens AC, Boldrick JC, Oragui EE, et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet. 2004;363(9404):203–9.

    Article  PubMed  CAS  Google Scholar 

  20. Pathan N, Franklin JL, Eleftherohorinou H, Wright VJ, Hemingway CA, Waddell SJ, et al. Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase. Crit Care Med. 2011;39(7):1692–711.

    Article  PubMed  CAS  Google Scholar 

  21. Stefoni S, La Manna G, Zanchelli F, Dalmastri V, Perna C, Pace G, et al. Clinical biology of artificial organ substitution. Nephrol Dial Transplant. 1998;13(Suppl 7):51–4.

    Article  PubMed  Google Scholar 

  22. Heidland A, Sebekova K, Schinzel R. Advanced glycation end products and the progressive course of renal disease. Am J Kidney Dis. 2001;38:S100–S106.

    Article  PubMed  CAS  Google Scholar 

  23. Panihi V, Miglion M, De Pietro S, Taccola D, Bianchi AM, Giovannini L, et al. C-reactive protein and interleukin-6 level are related to renal function in predialytic chronic renal failure. Nephron. 2002;91:594–600.

    Article  Google Scholar 

  24. Halter J, Steinberg J, Fink G, Lutz C, Picone A, Maybury R, et al. Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass. J Extra Corpor Technol. 2005;37(3):272–7.

    PubMed  PubMed Central  Google Scholar 

  25. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med. 1993;21:522–26.

    Article  PubMed  CAS  Google Scholar 

  26. Hirayama Y, Oda S, Tateishi Y, Sadahiro T, Nakamura M, Watanabe E, et al. Comparison of interleukin-6 removal properties among hemofilters consisting of varying membrane materials and surface areas: An in vitro study. Blood Purif. 2011;31:18–25.

    Article  PubMed  CAS  Google Scholar 

  27. Nakada T, Oda S, Hirosawa H, Sadahiro T, Nakamura M, Abe R, et al. Continuous hemodiafiltration with PMMA hemofilter in the treatment of patients with septic shock. Mol Med. 2008;14:257–63.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Matsuda K, Moriguchi T, Harii N, Goto J. Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure. Transfus Apher Sci. 2009;40:49–53.

    Article  PubMed  Google Scholar 

  29. Faubel S, Edelstein CL. Mechanisms and mediators of lung injury after acute kidney injury. Nat Rev Nephrol. 2016;12(1):48–60.

    Article  PubMed  CAS  Google Scholar 

  30. Yimin H, Wenkui Y, Jialiang S, Qiyi C, Juanhong S, Zhiliang L, et al. Effects of continuous renal replacement therapy on renal inflammatory cytokines during extracorporeal membrane oxygenation in a porcine model. J Cardiothorac Surg. 2013;29:8: 113.

    Article  Google Scholar 

  31. Shi J, Chen Q, Yu W, Shen J, Gong J, He C, et al. Continuous renal replacement therapy reduces the systemic and pulmonary inflammation induced by venovenous extracorporeal membrane oxygenation in a porcine model. Artif Organs. 2014;38(3):215 – 23.

    Article  PubMed  CAS  Google Scholar 

  32. Liu KD, Himmelfarb J, Paganini E, Ikizler TA, Soroko SH, Mehta RL, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1(5):915–9.

    Article  PubMed  CAS  Google Scholar 

  33. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care. 2009;24(1):129 – 40.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all the staff for their assistance in conducting this study. This research received no specific Grants from any funding agency in the public, commercial, or not-for-profit sectors.

Funding

This research received no specific Grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoshi Matsushita.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mukaida, H., Matsushita, S., Inotani, T. et al. Continuous renal replacement therapy with a polymethyl methacrylate membrane hemofilter suppresses inflammation in patients after open-heart surgery with cardiopulmonary bypass. J Artif Organs 21, 188–195 (2018). https://doi.org/10.1007/s10047-018-1025-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-018-1025-6

Keywords

Navigation